Cargando…

Osteonecrosis in Primary Antiphospholipid Syndrome is Associated with Previous Glucocorticoid Use and Thrombocytopenia

INTRODUCTION: The aim of this study was to investigate the frequency of avascular necrosis (AVN) and its associations with clinical and laboratory parameters in patients with primary antiphospholipid antibody syndrome (pAPS). METHODS: This was a cross-sectional study of 66 patients with pAPS who ful...

Descripción completa

Detalles Bibliográficos
Autores principales: Freire de Carvalho, Jozélio, Correia de Araujo, Roberto Paulo, Skare, Thelma Larocca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380619/
https://www.ncbi.nlm.nih.gov/pubmed/34228316
http://dx.doi.org/10.1007/s40744-021-00333-9
_version_ 1783741234122063872
author Freire de Carvalho, Jozélio
Correia de Araujo, Roberto Paulo
Skare, Thelma Larocca
author_facet Freire de Carvalho, Jozélio
Correia de Araujo, Roberto Paulo
Skare, Thelma Larocca
author_sort Freire de Carvalho, Jozélio
collection PubMed
description INTRODUCTION: The aim of this study was to investigate the frequency of avascular necrosis (AVN) and its associations with clinical and laboratory parameters in patients with primary antiphospholipid antibody syndrome (pAPS). METHODS: This was a cross-sectional study of 66 patients with pAPS who fulfilled the Sidney criteria for APS. Epidemiological and clinical data, and data on antiphospholipid antibodies were collected. Diagnosis of AVN was based on studies of magnetic resonance (MRI) images of affected bones. RESULTS: AVN was found in three of the 66 (4.5%) enrolled patients. Comparison of patients with pAPS with and without AVN showed that demographic data, comorbidities, and antiphospholipid antibodies profile were similar in both groups. Compared to patients without AVN, those with AVN had thrombocytopenia more frequently (66.7 vs. 7.9%) and used more glucocorticoids (100 vs. 35%). CONCLUSION: AVN is rare in patients with pAPS and may be associated with thrombocytopenia and previous glucocorticoid use.
format Online
Article
Text
id pubmed-8380619
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-83806192021-09-08 Osteonecrosis in Primary Antiphospholipid Syndrome is Associated with Previous Glucocorticoid Use and Thrombocytopenia Freire de Carvalho, Jozélio Correia de Araujo, Roberto Paulo Skare, Thelma Larocca Rheumatol Ther Original Research INTRODUCTION: The aim of this study was to investigate the frequency of avascular necrosis (AVN) and its associations with clinical and laboratory parameters in patients with primary antiphospholipid antibody syndrome (pAPS). METHODS: This was a cross-sectional study of 66 patients with pAPS who fulfilled the Sidney criteria for APS. Epidemiological and clinical data, and data on antiphospholipid antibodies were collected. Diagnosis of AVN was based on studies of magnetic resonance (MRI) images of affected bones. RESULTS: AVN was found in three of the 66 (4.5%) enrolled patients. Comparison of patients with pAPS with and without AVN showed that demographic data, comorbidities, and antiphospholipid antibodies profile were similar in both groups. Compared to patients without AVN, those with AVN had thrombocytopenia more frequently (66.7 vs. 7.9%) and used more glucocorticoids (100 vs. 35%). CONCLUSION: AVN is rare in patients with pAPS and may be associated with thrombocytopenia and previous glucocorticoid use. Springer Healthcare 2021-07-06 /pmc/articles/PMC8380619/ /pubmed/34228316 http://dx.doi.org/10.1007/s40744-021-00333-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Freire de Carvalho, Jozélio
Correia de Araujo, Roberto Paulo
Skare, Thelma Larocca
Osteonecrosis in Primary Antiphospholipid Syndrome is Associated with Previous Glucocorticoid Use and Thrombocytopenia
title Osteonecrosis in Primary Antiphospholipid Syndrome is Associated with Previous Glucocorticoid Use and Thrombocytopenia
title_full Osteonecrosis in Primary Antiphospholipid Syndrome is Associated with Previous Glucocorticoid Use and Thrombocytopenia
title_fullStr Osteonecrosis in Primary Antiphospholipid Syndrome is Associated with Previous Glucocorticoid Use and Thrombocytopenia
title_full_unstemmed Osteonecrosis in Primary Antiphospholipid Syndrome is Associated with Previous Glucocorticoid Use and Thrombocytopenia
title_short Osteonecrosis in Primary Antiphospholipid Syndrome is Associated with Previous Glucocorticoid Use and Thrombocytopenia
title_sort osteonecrosis in primary antiphospholipid syndrome is associated with previous glucocorticoid use and thrombocytopenia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380619/
https://www.ncbi.nlm.nih.gov/pubmed/34228316
http://dx.doi.org/10.1007/s40744-021-00333-9
work_keys_str_mv AT freiredecarvalhojozelio osteonecrosisinprimaryantiphospholipidsyndromeisassociatedwithpreviousglucocorticoiduseandthrombocytopenia
AT correiadearaujorobertopaulo osteonecrosisinprimaryantiphospholipidsyndromeisassociatedwithpreviousglucocorticoiduseandthrombocytopenia
AT skarethelmalarocca osteonecrosisinprimaryantiphospholipidsyndromeisassociatedwithpreviousglucocorticoiduseandthrombocytopenia